COST COMPARISON OF DIFFERENT FORMS OF ANDROGEN ABLATIVE THERAPIES IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN CANADA

被引：0
|
作者：
Dragomir, A. [1 ]
Vanhuyse, M. [1 ]
Aprikian, A. [1 ]
机构：
[1] McGill Univ, Montreal, PQ, Canada
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.453
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN58
引用
收藏
页码：A78 / A78
页数：1
相关论文
共 50 条
  • [1] Canadian cost comparison of different forms of androgen ablative therapies prior and during the castration-resistant prostate cancer
    Dragomir, Alice
    Vanhuyse, Marie
    Cury, Fabio L.
    Aprikian, Armen G.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] Androgen Receptor Directed Therapies in Castration-Resistant Metastatic Prostate Cancer
    Won Kim
    Charles J Ryan
    Current Treatment Options in Oncology, 2012, 13 : 189 - 200
  • [3] Androgen Receptor Directed Therapies in Castration-Resistant Metastatic Prostate Cancer
    Kim, Won
    Ryan, Charles J.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2012, 13 (02) : 189 - 200
  • [4] Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer Beyond the Androgen Receptor
    Loriot, Yohann
    Zoubeidi, Amina
    Gleave, Martin E.
    UROLOGIC CLINICS OF NORTH AMERICA, 2012, 39 (04) : 517 - +
  • [5] Drug therapies for metastatic castration-resistant prostate cancer
    El-Bahesh, Ehab
    Finianos, Antoine
    Alfaraj, Abeer
    Aragon-Ching, Jeanny B.
    FUTURE ONCOLOGY, 2015, 11 (17) : 2395 - 2403
  • [6] Advancing therapies in metastatic castration-resistant prostate cancer
    Baciarello, Giulia
    Gizzi, Marco
    Fizazi, Karim
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (16) : 1797 - 1804
  • [7] Comparing Cost and Utilization of 2 Therapies for Metastatic Castration-Resistant Prostate Cancer
    Mitchell, Matthew
    AMERICAN HEALTH AND DRUG BENEFITS, 2015, 8 (04): : 195 - 195
  • [8] Metastatic Castration-Resistant Prostate Cancer: Treatment Pathway and Associated Cost in Canada
    Dragomir, Alice
    Dinea, Daniela
    Vanhuyse, Marie
    Cury, Fabio
    Aprikian, Armen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 419 - 419
  • [9] Targeting the androgen receptor in metastatic castration-resistant prostate cancer
    Aragon-Ching, Jeanny B.
    FUTURE ONCOLOGY, 2014, 10 (03) : 329 - 332
  • [10] Bone Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer
    Rajpar, Shanna
    Fizazi, Karim
    CANCER JOURNAL, 2013, 19 (01): : 66 - 70
12345